Results 61 to 70 of about 14,162 (232)

Hidradenitis suppurativa [PDF]

open access: yesCanadian Medical Association Journal, 2015
R Gary, Sibbald, Asfandyar, Mufti
openaire   +5 more sources

40194 Polycystic Ovary Syndrome Diagnosis Does Not Predict Increased Hidradenitis Suppurativa Disease Severity [PDF]

open access: bronze, 2023
Sarah Romanelli   +6 more
openalex   +1 more source

Digital health applications, telemedicine and large language models in dermatology: results of a Germany‐wide survey

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Abstract Background: Digital technologies offer opportunities for dermatological care, but there is a lack of systematic data on their use and acceptance, particularly with regard to digital health applications (DiGA) and large language models (LLMs).
Lukas Henk   +9 more
wiley   +1 more source

Bidirectional Risk Association Between Hidradenitis Suppurativa and Inflammatory Bowel Disease

open access: yesActa Dermato-Venereologica
Hidradenitis suppurativa is an inflammatory skin disease of the pilosebaceous unit encompassing painful, recurrent, and malodorous abscesses, inflammatory nodules, dermal sinus tracts, and cicatrices.
Louise Lönndahl   +5 more
doaj   +1 more source

Clinical and Ultrasonographic Profile of Adalimumab-treated Hidradenitis Suppurativa Patients: A Real-life Monocentric Experience

open access: yesActa Dermato-Venereologica, 2020
Ultrasonography has proven useful for diagnosis and treatment monitoring in patients with hidradenitis suppurativa. The aim of this study was to assess the clinical response to adalimumab using ultrasound findings.
Andrea Chiricozzi   +8 more
doaj   +1 more source

Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns.
Yuliya Valdman‐Grinshpoun   +4 more
wiley   +1 more source

Polish guidelines for the diagnosis and treatment of hidradenitis suppurativa

open access: yesPrzegląd Dermatologiczny
Hidradenitis suppurativa is a chronic, recurrent, inflammatory skin disease that affects hair follicles, typically developing after puberty. It is characterized by painful, deep-seated inflammatory lesions that appear in anatomical regions where apocrine
Łukasz Matusiak   +11 more
doaj   +1 more source

Hidradenitis suppurativa and vasculitis: A case series and literature review of a rare association

open access: yesSAGE Open Medical Case Reports, 2019
Hidradenitis suppurativa is a chronic inflammatory skin disease with dysregulation of the immune system. Its pathophysiology is not clear, and it has been reported in association with various inflammatory disorders such as pyoderma gangrenosum, arthritis,
Afsaneh Alavi   +3 more
doaj   +1 more source

Super‐Response to Guselkumab Treatment in Patients With Moderate‐to‐Severe Psoriasis: Real‐World Data With Up to Five Years of Follow‐Up in The Czech Republic

open access: yesInternational Journal of Dermatology, EarlyView.
Super‐response to Guselkumab. ABSTRACT Background Guselkumab, a selective interleukin (IL)‐23 inhibitor, is approved for the treatment of moderate‐to‐severe plaque psoriasis. While randomized clinical trials have introduced the concept of “super‐responders” (SRe)—patients achieving complete skin clearance (Psoriasis Area and Severity Index [PASI] 100 ...
Martina Kojanova   +76 more
wiley   +1 more source

Global Patterns of Comorbidities Among Patients With Hidradenitis Suppurativa: A Systematic Review and Meta‐Analysis

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder increasingly recognized as a systemic disease with diverse comorbidities. While several comorbid conditions are well documented, regional differences in prevalence remain unclear.
Aditya K. Gupta   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy